Focus on Alternative and Complementary Therapies
www.pharmpress.com/fact
Focus Alternat Complement Ther©2005 Pharmaceutical Press
Focus Altern Complement Ther 2004; 9: 49
Grape seed proanthocyanidin extract (GSPE) treatment improves cardiomyocyte survival following ischemia/reperfusion (I/R). Since I/R injury in this system appears to be mediated in part via caspase activation while nitric oxide (NO) can be cardioprotective, we hypothesised that GSPE may decrease caspase-mediated I/R injury in chick cardiomyocytes via increased NO generation.
Cultured chick cardiomyocytes were perfused and monitored in a Sykes–Moore chamber during 1 h of simulated ischemia and 3 h of reperfusion. Oxidant generation was measured by 2′, 7′-dichlorifluorescin diacetate (DCFH/DA). NO production was determined by 4′,5′-diaminofluorescein diacetate (DAF-2DA). Viability was assessed by propidium iodide (PI). Caspase activity was measured by fluorogenic assay.
GSPE (10, 50 and 100 μg/ml) administered at the reperfusion dose-dependently attenuated the burst of DCF fluorescence. A significant reduction in cell death was observed from 44.9 ± 2.3% in I/R untreated cells to 17.8 ± 3.0% in GSPE-treated cells (50 μg/ml; n = 6, P < 0.001), with the return of contractions observed in the GSPE group. GSPE (50 μg/ml) significantly inhibited caspase 3, 2, 8, 9 activities compared to I/R untreated cells. When GSPE (50 μg/ml) was added at reperfusion DAF-2 fluorescence significantly increased and NG-nitro-L-arginine methyl ester (L-NAME), a NOS inhibitor, partially abolished caspase inhibition and abrogated GSPE-conferred protection against cell death (from 17.8 ± 3.0% to 33.5 ± 3.8%).
GSPE attenuates I/R-induced apoptosis in chick cardiomyocytes by inhibiting caspase activity. GSPE may mediate protection by stimulating NO production within the cardiomyocytes.
This work was supported by grants AT01575 and HL68951 from NIH, USA.